Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are commonly believed to be mutually exclusive. Studies have reported that concurrent EGFR/ALK co-mutation in non-small cell lung...
Saved in:
Main Authors: | Haoyue Hu (Author), Songtao Tan (Author), Meng Xie (Author), Peng Guo (Author), Qiang Yu (Author), Juan Xiao (Author), Kangrui Zhao (Author), Qiong Liao (Author), Yi Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report
by: Jun Fan, et al.
Published: (2020) -
A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
by: Ki-Chang Lee, et al.
Published: (2021) -
Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
by: Jonathan R. Thompson, et al.
Published: (2016) -
Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer
by: Ruiying Zhao, et al.
Published: (2022) -
Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non-Small Cell Lung Cancer
by: Dehua Liao, et al.
Published: (2022)